Securities PURCHASE AGREEMENTSecurities Purchase Agreement • August 17th, 2018 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of August 16, 2018, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
CONSULTANT AGREEMENTConsultant Agreement • August 17th, 2018 • Pure Bioscience, Inc. • Miscellaneous chemical products • California
This CONSULTING AGREEMENT (the “Agreement”) is entered into effective as of August 13, 2018 (the “Effective Date”), by and between Pure Bioscience, Inc., a Delaware corporation (the “Company”), and Dave Pfanzelter (the “Consultant”). The Company and the Consultant are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
